Research on Novel Formulation of Model Drug Containing Lidocaine Hydrochloride and Doxcycycline Hyclate for Periodontal Disease

Abstract

In the present day circumstances, it has been reported that the Dental diseases are a most important physical condition problem in all parts of the globe, general in all age groups, races and genders. The proportion of dental diseases has developed to a great extent in current years. Around 70% of inhabitants suffer from dental problems. The human population is exaggerated by foremost of oral diseases. To treat dental problems such as pain due to dental caries, periodonitis, gingivitis, and other gum infections, painkillers alongside with antibiotics and various dental paints are the generally prescribed drugs by dentists as primary mode of treatment. However the general side effects of most of the painkillers are hyperacidity and gastric annoyance upon oral administration. On the other hand, nearly all antibiotics due to measured onset of action and hepatic “first-pass” consequence fail to construct prompt and extend actions. Furthermore, most of the dental formulations are washed out by saliva inside a few hours of application. To conquer the above-mentioned problems, a soft polymeric mold containing antibiotic and anasthetics drugs and having a suitable constancy to stick to the tooth, was developed for continued drug release to endow with improved relief in dental patients. Carbopol 934, Ethyl cellulose, Gum tragacanth, Hydroxy propyl cellulose, and PEG 400 were used to organize the formulation containing Lidocaine hydrochloride and doxycycline hyclate individually and in combination, by addition and solvent evaporation technique. Dissimilar physicochemical characterization studies such as mucoadhesion test and swelling index were conceded out. In vitro drug release studies showed sustained release of Lidocaine hydrochloride and doxycycline hyclate in simulated saliva for 24 h. Additional studies are necessary to succeed with these formulations in humans. Upon accomplishment, this type of dosage form may open up new avenues towards dentistry.